In this time of information overabundance, much of which is inaccurate, unhelpful, or even difficult to understand, Northwell Health is on a mission to make a difference as an honest, trusted, and caring partner
Introduction Weekly injectable GLP1 medications like semaglutide and tirzepatide (known as Mounjaro, Zepbound, Wegovy, and Ozempic) have ushered in a new era of weightmanagement and diabetes care
Summary GLP-1 medications like Semaglutide (Ozempic, Wegovy) and Tirzepatide (Mounjaro, Zepbound) help people lose weight by targeting three systems at once: the gut (slowing digestion), the pancreas (improving insulin response), and the brain (reducing food cravings and food noise)
TRIUMPH-4 ran 68 weeks of continuous dosing under clinical supervision
How GLP-1 Medications Work GLP-1 receptor agonists mimic the bodys natural GLP-1 hormone, which helps signal the body to release more insulin when blood sugar is high
Eli Lilly, the compound developer, is running the Phase 3 TRIUMPH clinical trial program, and FDA approval is not expected before 2027 at the earliest
